This list is based on the watchlists of people on Stock Events who follow 9SO.F. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Solasia Pharma K.K. engages in the development and marketing of oncology drugs in Japan and other Asian countries. The company offers Episil, an oral liquid for oral mucositis/stomatitis; and DARVIAS, an antineoplastic agent injection for relapsed or refractory peripheral T-cell lymphoma. It also develops Sancuso for chemotherapy induced nausea and vomiting; SP-04, which is in preclinical trial development to treat chemotherapy peripheral neuropathy; and SP-05 for the treatment of colorectal cancer. The company was founded in 2006 and is based in Tokyo, Japan.
Show more...
FAQ
What is Solasia Pharma K.K. stock price today?▼
The current price of 9SO.F is €0.17 EUR — it has increased by +14.77% in the past 24 hours. Watch Solasia Pharma K.K. stock price performance more closely on the chart.
What is Solasia Pharma K.K. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Solasia Pharma K.K. stocks are traded under the ticker 9SO.F.
Is Solasia Pharma K.K. stock price growing?▼
9SO.F stock has risen by +11.04% compared to the previous week, the month change is a +3.64% rise, over the last year Solasia Pharma K.K. has showed a -12.31% decrease.
What is Solasia Pharma K.K. market cap?▼
Today Solasia Pharma K.K. has the market capitalization of 41.32M
When is the next Solasia Pharma K.K. earnings date?▼
Solasia Pharma K.K. is going to release the next earnings report on May 20, 2026.
What were Solasia Pharma K.K. earnings last quarter?▼
9SO.F earnings for the last quarter are -0 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Solasia Pharma K.K. revenue for the last year?▼
Solasia Pharma K.K. revenue for the last year amounts to 3.87M EUR.
What is Solasia Pharma K.K. net income for the last year?▼
9SO.F net income for the last year is -23.83M EUR.
How many employees does Solasia Pharma K.K. have?▼
As of April 02, 2026, the company has 23 employees.
In which sector is Solasia Pharma K.K. located?▼
Solasia Pharma K.K. operates in the Health Care sector.
When did Solasia Pharma K.K. complete a stock split?▼
Solasia Pharma K.K. has not had any recent stock splits.
Where is Solasia Pharma K.K. headquartered?▼
Solasia Pharma K.K. is headquartered in Tokyo, JP.